Forest Laboratories (NYS: FRX) reported earnings on Jan. 15. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q3), Forest Laboratories missed estimates on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue dropped significantly and GAAP earnings per share dropped to a loss.
Gross margins grew, operating margins dropped, net margins dropped.
Forest Laboratories chalked up revenue of $722.7 million. The 15 analysts polled by S&P Capital IQ expected revenue of $769.7 million on the same basis. GAAP reported sales were 40% lower than the prior-year quarter's $1.21 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.21. The 12 earnings estimates compiled by S&P Capital IQ anticipated -$0.05 per share. GAAP EPS were -$0.58 for Q3 versus $1.04 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 78.8%, 60 basis points better than the prior-year quarter. Operating margin was -25.5%, 5,500 basis points worse than the prior-year quarter. Net margin was -21.3%, 4,440 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $829.6 million. On the bottom line, the average EPS estimate is $0.18.
Next year's average estimate for revenue is $3.17 billion. The average EPS estimate is $0.54.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Forest Laboratories is hold, with an average price target of $37.26.
Add Forest Laboratories to My Watchlist.
The article Forest Laboratories Goes Negative originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.